相关实验视频

Updated: May 5, 2026

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes

Published on: September 18, 2017

在db/db小鼠中cMyBP-C酸化对心脏收缩功能障碍的作用

Darshini A Desai¹, Akhil Baby^1,2, Kalyani Ananthamohan¹

¹Center for Cardiovascular Research, Department of Internal Medicine, Division of Cardiovascular Health and Disease, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

Journal of molecular and cellular cardiology plus

|July 3, 2024

概括

2型糖尿病通过肌结合蛋白-C高酸化引起心肌疾病 (T2DM-CM). 像Mavacamten这样的心脏肌抑制剂在临床前模型中显示出拯救这种心脏功能障碍的希望.

科学领域:

心脏病学心脏病学
代谢疾病代谢疾病
分子生物学分子生物学

背景情况:

2型糖尿病 (T2DM) 与心脏功能障碍有关,特别是心力衰竭与保留射出分数 (HFpEF).
T2DM诱导心肌病 (T2DM-CM) 的分子基础在很大程度上是未知的.
心脏肌肉酶结合蛋白-C的过酸化与T2DM-CM病变发生有关.

研究的目的:

为了阐明T2DM-CM的分子机制.
为了研究心脏肌肉酶抑制剂对T2DM-CM的治疗潜力.

主要方法:

使用Lepr db/db小鼠作为T2DM-CM的模型.
进行心声回声扫描以评估心脏功能.
进行RNA-seq分析以确定差异调节的基因.
在实验室中研究了Mavacamten (MYK-461) 对心脏收缩性的影响.

主要成果:

Lepr db/db小鼠在6个月后表现出心脏功能障碍和左心室缩.
通过RNA-seq鉴定出与心脏功能障碍相关的失调基因.
在Lepr db/db心脏中,心脏髓素结合蛋白-C高酸化升高.
在db/db模型中,Mavacamten显著降低了肌肉力量和心肌细胞收缩率.

结论:

T2DM-CM与心脏髓素结合蛋白-C高酸化有关.
在实验室中,马瓦卡门在缓解T2DM-CM进展方面表现出有效性.
心脏肌抑制剂代表了T2DM诱导的HFpEF的潜在治疗策略.

关键词:

糖尿病糖尿病糖尿病 HFpEF HFpEF 的意思是什么在MYBPC3中,您可以使用MYBPC3.马瓦卡姆坦坦是什么意思酸化是指酸化的方法.cMyBP-C 的情况.

更多相关视频

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Analysis of Cardiac Contractile Dysfunction and Ca2+ Transients in Rodent Myocytes

Published on: May 25, 2022

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

相关概念视频

Cardiomyopathy II: Dilated Cardiomyopathy

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...